ListarMedicina, ciencias biomédicas y salud pública por tema "614.599 9449 Cáncer de mama"
Mostrando ítems 1-1 de 1
-
Neoadjuvant Metformin Added to Systemic Therapy Increases Pathological Complete Response in Breast Cancer: A Cross-sectional Study, Mexico Hospital, Costa Rica
(2018-02)Background: Metformin shows anti-proliferative effect on tumor cells. We studied the effect of metformin on achieving complete pathological response (pCR) in breast cancer patients receiving neoadjuvant therapy in a Latin ...